PDAC - Pancreatic Ductal Adenocarcinoma
Conditions
Brief summary
The objective of the present registry is the creation of a prospective registry collecting clinico-pathological and genomic data, along with survival outcomes, of individuals diagnosed with PDAC at or before the age of 55 years old. This registry is intended with the aim of using collected data for future clinical trials, both prospective and retrospective.
Interventions
OTHERRegister
Prospective collection of epidemiological, clinical, and pathological data of patients diagnosed with early-onset pancreatic cancer (EO-PDAC) - namely, individuals who have received a diagnosis of pancreatic cancer before, or at, the age of 55 years old.
Sponsors
Azienda Ospedaliera Universitaria Integrata Verona
Study design
Observational model
OTHER
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 55 Years
Inclusion criteria
* Age ≤55 years old at the time of diagnosis of pancreatic cancer * Age ≥ 18 years * Written informed consent obtained.
Exclusion criteria
* Any pancreatic neoplasm other than pancreatic cancer (e.g. cholangiocarcinoma, ampullary cancer,duodenal cancer, non-invasive mucinous cystic neoplasm, pancreatic intra-epithelial neoplasia 1 and 2, non-invasive intraductal papillary mucinous neoplasm, serous cystic neoplasm, pseudo papillary solid tumor, neuroendocrine tumor) * Absence of informed consent. * Age \< 18 years or \> 55 years old at the time of diagnosis of pancreatic cancer
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Register of young PDAC patients | 30 years | Prospective collection of epidemiological, clinical, and pathological data of patients diagnosed with early-onset pancreatic cancer (EO-PDAC) - namely, individuals who have received a diagnosis of pancreatic cancer before, or at, the age of 55 years old. |
Countries
Italy
Contacts
Primary ContactFabio Casciani
Outcome results
None listed